Nuclera CEO Michael Chen next to one of the eProtein Discovery boxes (Credit: Nuclera)
October 15, 2024 04:00 AM EDTUpdated 06:20 AM
Financing
Manufacturing

Ex­clu­sive: Biotech tools com­pa­ny rais­es $75M for pro­tein man­u­fac­tur­ing tech 

Anna Brown

News Reporter

Pro­tein pro­duc­tion com­pa­ny Nu­cle­ra has raised a $75 mil­lion Se­ries C to con­tin­ue to bring its man­u­fac­tur­ing plat­form to mar­ket next Jan­u­ary af­ter a soft …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times